These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. Brucker-Davis F; Oldfield EH; Skarulis MC; Doppman JL; Weintraub BD J Clin Endocrinol Metab; 1999 Feb; 84(2):476-86. PubMed ID: 10022404 [TBL] [Abstract][Full Text] [Related]
10. Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature. Yoenem A; Cakyr B; Azal O; Corakcy A; Kutlu M; Oezata M Endocr Regul; 1999 Dec; 33(4):169-74. PubMed ID: 10700085 [TBL] [Abstract][Full Text] [Related]
11. Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide). Caron P; Gerbeau C; Pradayrol L; Simonetta C; Bayard F J Clin Endocrinol Metab; 1996 Mar; 81(3):1164-8. PubMed ID: 8772594 [TBL] [Abstract][Full Text] [Related]
12. Reduction in size of a thyrotropin- and gonadotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog). Sy RA; Bernstein R; Chynn KY; Kourides IA J Clin Endocrinol Metab; 1992 Mar; 74(3):690-4. PubMed ID: 1740506 [TBL] [Abstract][Full Text] [Related]
13. Thyrotropin secreting pituitary adenoma accompanying a silent somatotropinoma. Berker D; Isik S; Aydin Y; Tutuncu Y; Akdemir G; Ozcan HN; Guler S Turk Neurosurg; 2011; 21(3):403-7. PubMed ID: 21845579 [TBL] [Abstract][Full Text] [Related]
14. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells. Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of the long-acting octreotide formulation in patients with thyroid-stimulating hormone-secreting pituitary adenomas after incomplete surgery and octreotide treatment failure. Zhang CF; Liang D; Zhong LY Chin Med J (Engl); 2012 Aug; 125(15):2758-63. PubMed ID: 22931988 [TBL] [Abstract][Full Text] [Related]
16. Clinical and immunohistochemical studies on TSH-secreting pituitary adenoma: its multihormonality and expression of Pit-1. Sanno N; Teramoto A; Matsuno A; Inada K; Itoh J; Osamura RY Mod Pathol; 1994 Dec; 7(9):893-9. PubMed ID: 7892156 [TBL] [Abstract][Full Text] [Related]
17. Absence of receptors for thyrotropin (TSH)-releasing hormone in human TSH-secreting pituitary adenomas associated with hyperthyroidism. Chanson P; Li JY; Le Dafniet M; Derome P; Kujas M; Murat A; Charpentier G; Racadot J; Peillon F J Clin Endocrinol Metab; 1988 Feb; 66(2):447-50. PubMed ID: 2828411 [TBL] [Abstract][Full Text] [Related]
18. Follicular thyroid carcinoma with metastases to the pituitary causing pituitary insufficiency. Vianello F; Mazzarotto R; Taccaliti A; Lora O; Basso M; Servodio O; Mian C; Sotti G Thyroid; 2011 Aug; 21(8):921-5. PubMed ID: 21595558 [TBL] [Abstract][Full Text] [Related]
19. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. Losa M; Giovanelli M; Persani L; Mortini P; Faglia G; Beck-Peccoz P J Clin Endocrinol Metab; 1996 Aug; 81(8):3084-90. PubMed ID: 8768879 [TBL] [Abstract][Full Text] [Related]